P64 Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir

• N. Reau,
• M. Robertson,
• H.P. Feng,
• L. Caro,
• W.W. Yeh,
• B.Y.T. Nguyen,
• J. Wahl,
• E. Barr,
• P. Hwang,
• S.O. Klopfer

Affiliations

N. Reau

Rush University Medical Center, Chicago, IL, USA

M. Robertson

Merck & Co, Inc, Kenilworth, NJ, USA

H.P. Feng

Merck & Co, Inc, Kenilworth, NJ, USA

L. Caro

Merck & Co, Inc, Kenilworth, NJ, USA

W.W. Yeh

Merck & Co, Inc, Kenilworth, NJ, USA

B.Y.T. Nguyen

Merck & Co, Inc, Kenilworth, NJ, USA

J. Wahl

Merck & Co, Inc, Kenilworth, NJ, USA

E. Barr

Merck & Co, Inc, Kenilworth, NJ, USA

P. Hwang

Merck & Co, Inc, Kenilworth, NJ, USA

S.O. Klopfer

Merck & Co, Inc, Kenilworth, NJ, USA